Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHA:688393)
China flag China · Delayed Price · Currency is CNY
30.17
+1.31 (4.54%)
At close: Jan 23, 2026

Guangzhou LBP Medicine Science & Technology Company Description

Guangzhou LBP Medicine Science & Technology Co., Ltd. engages in the research, development, and production of pathological diagnosis products in China and internationally.

The company offers pathological diagnostic reagents and ancillary equipment that consists of liquid-based cytology products, including liquid-based cytology production machines and automatic sample transfer machines; polymerase chain reaction products, such as human papillomavirus gene test kits, sample preservation solutions, and automatic nucleic acid molecular hybridization instruments; fluorescence in situ hybridization products comprising auto-fish instruments, and AML1/ETO, EGFR, BCR/ABL fusion, PML/RARA, and TOP2A gene testing kits; and digital pathology products pathological medical image analysis processing systems, real-time microscopic visual field sharing systems, and bingli scanner.

It also provides immunohistochemistry products including automatic antigen repair instrument and automatic immunocytochemical staining machine, as well as conversional pathology equipment.

The company was founded in 2005 and is based in Guangzhou, China.

Guangzhou LBP Medicine Science & Technology Co., Ltd.
CountryChina
Founded2005
IndustryMedical Instruments & Supplies
SectorHealthcare
Employees779
CEOXiangting Cai

Contact Details

Address:
No. 2, Kexin Street
Guangzhou, 510663
China
Phone86 20 3229 9997
Websitegzlbp.com

Stock Details

Ticker Symbol688393
ExchangeShanghai Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberCNE1000043R4
SIC Code3845

Key Executives

NamePosition
Xiangting CaiChairman of the Board and GM
Quanneng HouChief Financial Officer and Board Secretary
Zhefeng DengDeputy GM and Director
Zongsheng LiangDeputy GM and Director
Aiping HuangAccounting Supervisor